1. Volume 381, Issue 9868, Pages 744-751 (March 2013)
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial 
Andrew Howman, MMath, Tracey L Chapman, Maria M Langdon, MSc, Caroline Ferguson, BSc, Dwomoa Adu, MD, Prof John Feehally, DM, Gillian J Gaskin, PhD, David RW Jayne, MD, Prof Donal O'Donoghue, MB, Michael Boulton-Jones, FRCP, Prof Peter W Mathieson, FRCP 
The Lancet 
Volume 381, Issue 9868, Pages (March 2013)
DOI: /S (12)
Copyright © 2013 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
The Lancet  , DOI: ( /S (12) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

3. Figure 2
Kaplan-Meier analysis of further 20% decline in renal function
Deaths were censored. GFR=glomerular filtration rate.
The Lancet  , DOI: ( /S (12) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

4. Figure 3 Change in measured or calculated 24-h urinary protein
Datapoints show mean change in 24-h urinary protein from baseline; error bars show 95% CI. The numbers of patients from whom readings were taken at each timepoint are presented; variation in numbers was due to dropout and missing readings at those timepoints.
The Lancet  , DOI: ( /S (12) )
Copyright © 2013 Elsevier Ltd Terms and Conditions